🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

16+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 16 of 16 recruiting trials for “Primary membranous glomerulonephritis”

Phase 2RecruitingNCT07289763 ↗

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

🏥 Guangdong Hengrui Pharmaceutical Co., Ltd📍 1 site📅 Started Dec 2025View details ↗
Phase 2, PHASE3RecruitingNCT07204275 ↗

A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

🏥 Vertex Pharmaceuticals Incorporated📍 73 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07157787 ↗

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

🏥 Alexion Pharmaceuticals, Inc.📍 39 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07096843 ↗

A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

🏥 Climb Bio, Inc.📍 33 sites📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT06962800 ↗

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

👨‍⚕️ Medical Director, Biogen📍 78 sites📅 Started May 2025View details ↗
Phase 1RecruitingNCT06982729 ↗

Study of YK012 in Primary Membranous Nephropathy

👨‍⚕️ Minghui Zhao, M.D., Peking University First Hospital📍 1 site📅 Started Mar 2025View details ↗
RecruitingNCT06242327 ↗

An Outcome Analysis of Primary Membranous Nephropathy

👨‍⚕️ Giuseppe Remuzzi, MD, Istituto Di Ricerche Farmacologiche Mario Negri📍 2 sites📅 Started Nov 2024View details ↗
RecruitingNCT06893328 ↗

A Real World Study About PMN

🏥 Wei Chen📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06781944 ↗

OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

🏥 Huashan Hospital📍 1 site📅 Started Oct 2024View details ↗
Phase 2, PHASE3RecruitingNCT06470191 ↗

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 21 sites📅 Started Jul 2024View details ↗
Phase 4RecruitingNCT05514015 ↗

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

🏥 First Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Mar 2024View details ↗
Phase 1RecruitingNCT05800873 ↗

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

🏥 Everest Medicines (China) Co.,Ltd.📍 19 sites📅 Started May 2023View details ↗
Phase 3RecruitingNCT05696613 ↗

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

🏥 Cerium Pharmaceuticals, Inc.📍 31 sites📅 Started Mar 2023View details ↗
Phase 1RecruitingNCT05668403 ↗

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

🏥 Shanghai Jiaolian Drug Research and Development Co., Ltd📍 6 sites📅 Started Mar 2023View details ↗
Phase 2RecruitingNCT03949855 ↗

Belimumab With Rituximab for Primary Membranous Nephropathy

👨‍⚕️ Patrick Nachman, University of Minnesota, Department of Medicine, Division of Renal Diseases and Hypertension📍 20 sites📅 Started Mar 2020View details ↗
NARecruitingNCT05679336 ↗

Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy

👨‍⚕️ Vladimir Dobronravov, Professor, St. Petersburg State Pavlov Medical University📍 1 site📅 Started May 2018View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →